FR2508907A1 - Esters d'hydroxybenzenes substitues de 2-thenoylmercaptopropionylglycine utiles notamment comme mucolytiques, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Esters d'hydroxybenzenes substitues de 2-thenoylmercaptopropionylglycine utiles notamment comme mucolytiques, procede pour leur preparation et compositions pharmaceutiques les contenant Download PDF

Info

Publication number
FR2508907A1
FR2508907A1 FR8211684A FR8211684A FR2508907A1 FR 2508907 A1 FR2508907 A1 FR 2508907A1 FR 8211684 A FR8211684 A FR 8211684A FR 8211684 A FR8211684 A FR 8211684A FR 2508907 A1 FR2508907 A1 FR 2508907A1
Authority
FR
France
Prior art keywords
acetamidophenyl
compounds
preparation
thenoylmercaptopropionylglycin
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8211684A
Other languages
English (en)
French (fr)
Other versions
FR2508907B1 (US20110232667A1-20110929-C00004.png
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of FR2508907A1 publication Critical patent/FR2508907A1/fr
Application granted granted Critical
Publication of FR2508907B1 publication Critical patent/FR2508907B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
FR8211684A 1981-07-02 1982-07-02 Esters d'hydroxybenzenes substitues de 2-thenoylmercaptopropionylglycine utiles notamment comme mucolytiques, procede pour leur preparation et compositions pharmaceutiques les contenant Granted FR2508907A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48807/81A IT1143209B (it) 1981-07-02 1981-07-02 Esteri della 2-tenoilmercaptopropionil glicina con idrossibenzeni sostituiti procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Publications (2)

Publication Number Publication Date
FR2508907A1 true FR2508907A1 (fr) 1983-01-07
FR2508907B1 FR2508907B1 (US20110232667A1-20110929-C00004.png) 1984-12-28

Family

ID=11268648

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8211684A Granted FR2508907A1 (fr) 1981-07-02 1982-07-02 Esters d'hydroxybenzenes substitues de 2-thenoylmercaptopropionylglycine utiles notamment comme mucolytiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (19)

Country Link
US (1) US4472424A (US20110232667A1-20110929-C00004.png)
JP (1) JPS5810577A (US20110232667A1-20110929-C00004.png)
KR (1) KR860001311B1 (US20110232667A1-20110929-C00004.png)
AT (1) ATA255682A (US20110232667A1-20110929-C00004.png)
BE (1) BE893712A (US20110232667A1-20110929-C00004.png)
CA (1) CA1198735A (US20110232667A1-20110929-C00004.png)
CH (1) CH651035A5 (US20110232667A1-20110929-C00004.png)
DE (1) DE3224824A1 (US20110232667A1-20110929-C00004.png)
DK (1) DK153760C (US20110232667A1-20110929-C00004.png)
ES (1) ES514456A0 (US20110232667A1-20110929-C00004.png)
FR (1) FR2508907A1 (US20110232667A1-20110929-C00004.png)
GB (1) GB2102797B (US20110232667A1-20110929-C00004.png)
GR (1) GR76187B (US20110232667A1-20110929-C00004.png)
IE (1) IE53190B1 (US20110232667A1-20110929-C00004.png)
IL (1) IL66190A0 (US20110232667A1-20110929-C00004.png)
IT (1) IT1143209B (US20110232667A1-20110929-C00004.png)
LU (1) LU84245A1 (US20110232667A1-20110929-C00004.png)
NL (1) NL8202658A (US20110232667A1-20110929-C00004.png)
SE (1) SE8204116L (US20110232667A1-20110929-C00004.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013883A1 (en) * 1990-03-05 1991-09-19 Yason S.R.L. S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114963A (en) * 1991-03-13 1992-05-19 Medicis Corporation Method of reducing serum levels of lipoprotein(A)
WO2002016832A1 (fr) * 2000-08-18 2002-02-28 Hokko Sohgoh Kaihatsu K.K. Dispositif de chauffage de sol, conduit calorique a siphon thermique et procede de fabrication dudit conduit calorique

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422657A1 (fr) * 1978-04-11 1979-11-09 Mediolanum Farmaceutici Srl 2-(2-thenoylthio)-propionylglycine, procede pour sa preparation et compositions pharmaceutiques la contenant
EP0013261A1 (en) * 1978-12-21 1980-07-09 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Guaiacol esters of alpha- and beta-mercaptopropionylalanine and alpha- and beta-mercaptopropionylglycine, process for their preparation and pharmaceutical compositions containing same
EP0044504A1 (en) * 1980-07-22 1982-01-27 NEOPHARMED S.p.A. A derivative of theonyl thio-propionyl-glycine and process for the preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1149884B (it) * 1980-06-03 1986-12-10 Btb Ind Chimica Prozedimento per la preparazione della n-(2-tenoil)tiopropionil)-glicina
IE52884B1 (en) * 1981-05-11 1988-03-30 Sigma Tau Ind Farmaceuti 2-methoxyphenyl esters of n-substituted amino acids, their preparation and pharmaceutical use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422657A1 (fr) * 1978-04-11 1979-11-09 Mediolanum Farmaceutici Srl 2-(2-thenoylthio)-propionylglycine, procede pour sa preparation et compositions pharmaceutiques la contenant
EP0013261A1 (en) * 1978-12-21 1980-07-09 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Guaiacol esters of alpha- and beta-mercaptopropionylalanine and alpha- and beta-mercaptopropionylglycine, process for their preparation and pharmaceutical compositions containing same
EP0044504A1 (en) * 1980-07-22 1982-01-27 NEOPHARMED S.p.A. A derivative of theonyl thio-propionyl-glycine and process for the preparation thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013883A1 (en) * 1990-03-05 1991-09-19 Yason S.R.L. S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity

Also Published As

Publication number Publication date
CH651035A5 (it) 1985-08-30
SE8204116L (sv) 1983-01-03
US4472424A (en) 1984-09-18
IT8148807A0 (it) 1981-07-02
ES8306369A1 (es) 1983-06-01
IL66190A0 (en) 1982-11-30
ATA255682A (de) 1990-05-15
GB2102797B (en) 1985-01-30
GR76187B (US20110232667A1-20110929-C00004.png) 1984-08-03
IT1143209B (it) 1986-10-22
LU84245A1 (fr) 1983-01-20
GB2102797A (en) 1983-02-09
DE3224824A1 (de) 1983-01-27
CA1198735A (en) 1985-12-31
DK153760C (da) 1989-01-09
BE893712A (fr) 1982-10-18
DK294982A (da) 1983-01-03
KR840000235A (ko) 1984-02-18
NL8202658A (nl) 1983-02-01
JPS5810577A (ja) 1983-01-21
FR2508907B1 (US20110232667A1-20110929-C00004.png) 1984-12-28
KR860001311B1 (ko) 1986-09-13
IE821483L (en) 1983-01-02
ES514456A0 (es) 1983-06-01
SE8204116D0 (sv) 1982-07-02
IE53190B1 (en) 1988-08-17
DK153760B (da) 1988-08-29

Similar Documents

Publication Publication Date Title
DE2228012C3 (de) Phthalidester der 6- [D(-)- a Aminophenylacetamido] -penicillansäure und Verfahren zu seiner Herstellung
EP0318377A2 (fr) Nouveaux composés énantiomères dérivés d'amino-acides, leur procédé de préparation et leurs applications thérapeutiques
FR2527204A1 (fr) Nouveaux composes utiles comme medicaments anti-allergiques et procede et intermediaires pour leur separation
FR2522324A1 (fr) Pyrrole-acetamides, leur procede de preparation et composition therapeutique les contenant
EP0087378B1 (fr) Ethers-oximes d'alcoylaminoalcools comme médicaments, produits nouveaux et procédés pour leur préparation
EP0038343B1 (de) Substituierte oxocarbonsäuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
CH646687A5 (fr) Derives de l'acide cyclohexane carboxylique.
US20030013762A1 (en) 6-methoxy-2-naphthylacetic acid prodrugs
EP0133935A2 (de) p-Oxibenzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln mit hypolipämischer Wirkung
FR2634766A1 (fr) Acides (rs)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofurannyl)-acetiques, et acides 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzofurannyl)-acetiques et leurs esters, utiles comme medicaments mucoregulateurs et anti-ischemiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2508907A1 (fr) Esters d'hydroxybenzenes substitues de 2-thenoylmercaptopropionylglycine utiles notamment comme mucolytiques, procede pour leur preparation et compositions pharmaceutiques les contenant
EP0089894A1 (fr) (Benzimidazolyl-1)-1,N-((hydroxy-4 méthoxy-3 phényl)-2 hydroxy-2 éthyl) amino-3 butane et ses sels et hydrates à activité bêta-adrénergique, leurs applications thérapeutiques, et procédé pour les préparer
JP2003512424A (ja) 6−メトキシ−2−ナフチル酢酸プロドラッグ
CH654289A5 (fr) Medicaments constitues par certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant.
CH615673A5 (US20110232667A1-20110929-C00004.png)
LU84062A1 (fr) Esters de mercaptoacyl-carnitines,procede pour leur preparation et leurs utilisations therapeutiques,notamment dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques
FR2517672A1 (fr) Thioalcanoyl-carnitines, procede pour leur preparation et composition pharmaceutique les contenant
CA1076117A (fr) Procede d'obtention de nouveaux ethers aryliques et les produits en resultant
EP0061406B1 (fr) Dérivés d'acide benzamido-alkyl-hydroxamique, procédé de préparation et composition thérapeutique
CH641775A5 (fr) N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, son procede de preparation et composition le renferment.
FR2845385A1 (fr) Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique
BE897156A (fr) Derives du dithioiane, leur preparation et leur utilisation
JP3857428B2 (ja) 抗真菌剤
LU84142A1 (fr) Esters 2-methoxyphenyliques d'amino-acides n-substitues,procede pour leur preparation et compositions pharmaceutiques les contenant
EP0123605A1 (fr) N-Cyclopropylméthyl-2 oxo-3 diparaméthoxyphenyl 5-6 as triazine, son procédé de fabrication et son utilisation en tant que médicament

Legal Events

Date Code Title Description
ST Notification of lapse